Study of aortic aneurysm and aortic stenosis via analyzing the genome and transomics analyses.

Study for clarifying the pathophysiology of aortic aneurysm and aortic stenosis via analyzing the genome and transomics analyses. - The genome and transomics analyses of aortic aneurysm and aortic stenosis.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047463

Enrollment

200

Registered

2022-05-01

Start date

2022-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic aneurysm / Aortic stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hospitalized patients of aortic aneurysm and aortic stenosis.

Exclusion criteria

Exclusion criteria: Patients under using prednisolone, Cancer patients under treatment, Psychosis and dementia patients

Design outcomes

Primary

Measure	Time frame
The evidence of the involvement of somatic gene mutation in the pathophysiology of aortic aneurysm and aortic stenosis.	—

Secondary

Measure	Time frame
Epigenome, transcriptome, and proteome data of the lesions. Plasma metabolome data. Gut microbiota metagenome data.	—

Countries

Japan

Contacts

Public ContactTomoya Yamashita

Kobe University Hospital Division of Cardiovascular Medicine

tomoya@med.kobe-u.ac.jp078-382-5846

Outcome results